カテゴリー： Market Monitor Global, 世界, 医療/バイオ

新型薬物再構成システムの世界市場見通し2023年-2029年

◆英語タイトル：Novel Drug Reconstitution System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5389）◆商品コード：MMG23JU5389
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Novel Drug Reconstitution System Market 調査レポートは次の情報を含め、グローバルにおけるの新型薬物再構成システム市場規模と予測を収録しています。・世界の新型薬物再構成システム市場：売上、2018年-2023年、2024年-2029年
・世界の新型薬物再構成システム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の新型薬物再構成システム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「瓶詰め」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

新型薬物再構成システムのグローバル主要企業は、3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、新型薬物再構成システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の新型薬物再構成システム市場：タイプ別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：タイプ別市場シェア、2022年
・瓶詰め、袋詰め

世界の新型薬物再構成システム市場：用途別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の新型薬物再構成システム市場：地域・国別、2018年-2023年、2024年-2029年
世界の新型薬物再構成システム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における新型薬物再構成システムのグローバル売上、2018年-2023年
・主要企業における新型薬物再構成システムのグローバル売上シェア、2022年
・主要企業における新型薬物再構成システムのグローバル販売量、2018年-2023年
・主要企業における新型薬物再構成システムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceutical

*************************************************************

・調査・分析レポートの概要
新型薬物再構成システム市場の定義
市場セグメント
世界の新型薬物再構成システム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の新型薬物再構成システム市場規模
世界の新型薬物再構成システム市場規模：2022年 VS 2029年
世界の新型薬物再構成システム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの新型薬物再構成システムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の新型薬物再構成システム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：瓶詰め、袋詰め
新型薬物再構成システムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
新型薬物再構成システムの用途別グローバル売上・予測

・地域別市場分析
地域別新型薬物再構成システム市場規模 2022年と2029年
地域別新型薬物再構成システム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
3M Innovative Properties、 Baxter、 JW Group、 Pfizer、 Takeda、 Aerie Pharmaceuticals、 Ionis Pharmaceuticals、 Eisai、 Covis Pharma、 Allergan、 Gilead Sciences、 Bayer Healthcare、 Credence Medsystems、 Amgen、 Roche、 GlaxoSmithKline、 Vertex Pharmaceuticals、 Synergy Pharmaceuticals、 Otsuka Pharmaceutical
...

This report aims to provide a comprehensive presentation of the global market for Novel Drug Reconstitution System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Reconstitution System. This report contains market size and forecasts of Novel Drug Reconstitution System in global, including the following market information:
Global Novel Drug Reconstitution System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Novel Drug Reconstitution System Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Novel Drug Reconstitution System companies in 2022 (%)
The global Novel Drug Reconstitution System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Bottled Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Novel Drug Reconstitution System include 3M Innovative Properties, Baxter, JW Group, Pfizer, Takeda, Aerie Pharmaceuticals, Ionis Pharmaceuticals, Eisai and Covis Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Drug Reconstitution System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Drug Reconstitution System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, by Type, 2022 (%)
Bottled
Bagged
Global Novel Drug Reconstitution System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Novel Drug Reconstitution System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Novel Drug Reconstitution System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Drug Reconstitution System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Novel Drug Reconstitution System revenues share in global market, 2022 (%)
Key companies Novel Drug Reconstitution System sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Novel Drug Reconstitution System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Innovative Properties
Baxter
JW Group
Pfizer
Takeda
Aerie Pharmaceuticals
Ionis Pharmaceuticals
Eisai
Covis Pharma
Allergan
Gilead Sciences
Bayer Healthcare
Credence Medsystems
Amgen
Roche
GlaxoSmithKline
Vertex Pharmaceuticals
Synergy Pharmaceuticals
Otsuka Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Novel Drug Reconstitution System, market overview.
Chapter 2: Global Novel Drug Reconstitution System market size in revenue and volume.
Chapter 3: Detailed analysis of Novel Drug Reconstitution System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Novel Drug Reconstitution System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Novel Drug Reconstitution System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Novel Drug Reconstitution System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Drug Reconstitution System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Drug Reconstitution System Overall Market Size
2.1 Global Novel Drug Reconstitution System Market Size: 2022 VS 2029
2.2 Global Novel Drug Reconstitution System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Novel Drug Reconstitution System Sales: 2018-2029
3 Company Landscape
3.1 Top Novel Drug Reconstitution System Players in Global Market
3.2 Top Global Novel Drug Reconstitution System Companies Ranked by Revenue
3.3 Global Novel Drug Reconstitution System Revenue by Companies
3.4 Global Novel Drug Reconstitution System Sales by Companies
3.5 Global Novel Drug Reconstitution System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Novel Drug Reconstitution System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Novel Drug Reconstitution System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Novel Drug Reconstitution System Players in Global Market
3.8.1 List of Global Tier 1 Novel Drug Reconstitution System Companies
3.8.2 List of Global Tier 2 and Tier 3 Novel Drug Reconstitution System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Novel Drug Reconstitution System Market Size Markets, 2022 & 2029
4.1.2 Bottled
4.1.3 Bagged
4.2 By Type – Global Novel Drug Reconstitution System Revenue & Forecasts
4.2.1 By Type – Global Novel Drug Reconstitution System Revenue, 2018-2023
4.2.2 By Type – Global Novel Drug Reconstitution System Revenue, 2024-2029
4.2.3 By Type – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
4.3 By Type – Global Novel Drug Reconstitution System Sales & Forecasts
4.3.1 By Type – Global Novel Drug Reconstitution System Sales, 2018-2023
4.3.2 By Type – Global Novel Drug Reconstitution System Sales, 2024-2029
4.3.3 By Type – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
4.4 By Type – Global Novel Drug Reconstitution System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Novel Drug Reconstitution System Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Novel Drug Reconstitution System Revenue & Forecasts
5.2.1 By Application – Global Novel Drug Reconstitution System Revenue, 2018-2023
5.2.2 By Application – Global Novel Drug Reconstitution System Revenue, 2024-2029
5.2.3 By Application – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
5.3 By Application – Global Novel Drug Reconstitution System Sales & Forecasts
5.3.1 By Application – Global Novel Drug Reconstitution System Sales, 2018-2023
5.3.2 By Application – Global Novel Drug Reconstitution System Sales, 2024-2029
5.3.3 By Application – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
5.4 By Application – Global Novel Drug Reconstitution System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Novel Drug Reconstitution System Market Size, 2022 & 2029
6.2 By Region – Global Novel Drug Reconstitution System Revenue & Forecasts
6.2.1 By Region – Global Novel Drug Reconstitution System Revenue, 2018-2023
6.2.2 By Region – Global Novel Drug Reconstitution System Revenue, 2024-2029
6.2.3 By Region – Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
6.3 By Region – Global Novel Drug Reconstitution System Sales & Forecasts
6.3.1 By Region – Global Novel Drug Reconstitution System Sales, 2018-2023
6.3.2 By Region – Global Novel Drug Reconstitution System Sales, 2024-2029
6.3.3 By Region – Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Novel Drug Reconstitution System Revenue, 2018-2029
6.4.2 By Country – North America Novel Drug Reconstitution System Sales, 2018-2029
6.4.3 US Novel Drug Reconstitution System Market Size, 2018-2029
6.4.4 Canada Novel Drug Reconstitution System Market Size, 2018-2029
6.4.5 Mexico Novel Drug Reconstitution System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Novel Drug Reconstitution System Revenue, 2018-2029
6.5.2 By Country – Europe Novel Drug Reconstitution System Sales, 2018-2029
6.5.3 Germany Novel Drug Reconstitution System Market Size, 2018-2029
6.5.4 France Novel Drug Reconstitution System Market Size, 2018-2029
6.5.5 U.K. Novel Drug Reconstitution System Market Size, 2018-2029
6.5.6 Italy Novel Drug Reconstitution System Market Size, 2018-2029
6.5.7 Russia Novel Drug Reconstitution System Market Size, 2018-2029
6.5.8 Nordic Countries Novel Drug Reconstitution System Market Size, 2018-2029
6.5.9 Benelux Novel Drug Reconstitution System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Novel Drug Reconstitution System Revenue, 2018-2029
6.6.2 By Region – Asia Novel Drug Reconstitution System Sales, 2018-2029
6.6.3 China Novel Drug Reconstitution System Market Size, 2018-2029
6.6.4 Japan Novel Drug Reconstitution System Market Size, 2018-2029
6.6.5 South Korea Novel Drug Reconstitution System Market Size, 2018-2029
6.6.6 Southeast Asia Novel Drug Reconstitution System Market Size, 2018-2029
6.6.7 India Novel Drug Reconstitution System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Novel Drug Reconstitution System Revenue, 2018-2029
6.7.2 By Country – South America Novel Drug Reconstitution System Sales, 2018-2029
6.7.3 Brazil Novel Drug Reconstitution System Market Size, 2018-2029
6.7.4 Argentina Novel Drug Reconstitution System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Novel Drug Reconstitution System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Novel Drug Reconstitution System Sales, 2018-2029
6.8.3 Turkey Novel Drug Reconstitution System Market Size, 2018-2029
6.8.4 Israel Novel Drug Reconstitution System Market Size, 2018-2029
6.8.5 Saudi Arabia Novel Drug Reconstitution System Market Size, 2018-2029
6.8.6 UAE Novel Drug Reconstitution System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M Innovative Properties
7.1.1 3M Innovative Properties Company Summary
7.1.2 3M Innovative Properties Business Overview
7.1.3 3M Innovative Properties Novel Drug Reconstitution System Major Product Offerings
7.1.4 3M Innovative Properties Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.1.5 3M Innovative Properties Key News & Latest Developments
7.2 Baxter
7.2.1 Baxter Company Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Novel Drug Reconstitution System Major Product Offerings
7.2.4 Baxter Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.2.5 Baxter Key News & Latest Developments
7.3 JW Group
7.3.1 JW Group Company Summary
7.3.2 JW Group Business Overview
7.3.3 JW Group Novel Drug Reconstitution System Major Product Offerings
7.3.4 JW Group Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.3.5 JW Group Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Novel Drug Reconstitution System Major Product Offerings
7.4.4 Pfizer Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Takeda
7.5.1 Takeda Company Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Novel Drug Reconstitution System Major Product Offerings
7.5.4 Takeda Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.5.5 Takeda Key News & Latest Developments
7.6 Aerie Pharmaceuticals
7.6.1 Aerie Pharmaceuticals Company Summary
7.6.2 Aerie Pharmaceuticals Business Overview
7.6.3 Aerie Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.6.4 Aerie Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.6.5 Aerie Pharmaceuticals Key News & Latest Developments
7.7 Ionis Pharmaceuticals
7.7.1 Ionis Pharmaceuticals Company Summary
7.7.2 Ionis Pharmaceuticals Business Overview
7.7.3 Ionis Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.7.4 Ionis Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.7.5 Ionis Pharmaceuticals Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Novel Drug Reconstitution System Major Product Offerings
7.8.4 Eisai Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Covis Pharma
7.9.1 Covis Pharma Company Summary
7.9.2 Covis Pharma Business Overview
7.9.3 Covis Pharma Novel Drug Reconstitution System Major Product Offerings
7.9.4 Covis Pharma Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.9.5 Covis Pharma Key News & Latest Developments
7.10 Allergan
7.10.1 Allergan Company Summary
7.10.2 Allergan Business Overview
7.10.3 Allergan Novel Drug Reconstitution System Major Product Offerings
7.10.4 Allergan Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.10.5 Allergan Key News & Latest Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Summary
7.11.2 Gilead Sciences Novel Drug Reconstitution System Business Overview
7.11.3 Gilead Sciences Novel Drug Reconstitution System Major Product Offerings
7.11.4 Gilead Sciences Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.11.5 Gilead Sciences Key News & Latest Developments
7.12 Bayer Healthcare
7.12.1 Bayer Healthcare Company Summary
7.12.2 Bayer Healthcare Novel Drug Reconstitution System Business Overview
7.12.3 Bayer Healthcare Novel Drug Reconstitution System Major Product Offerings
7.12.4 Bayer Healthcare Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.12.5 Bayer Healthcare Key News & Latest Developments
7.13 Credence Medsystems
7.13.1 Credence Medsystems Company Summary
7.13.2 Credence Medsystems Novel Drug Reconstitution System Business Overview
7.13.3 Credence Medsystems Novel Drug Reconstitution System Major Product Offerings
7.13.4 Credence Medsystems Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.13.5 Credence Medsystems Key News & Latest Developments
7.14 Amgen
7.14.1 Amgen Company Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Novel Drug Reconstitution System Major Product Offerings
7.14.4 Amgen Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.14.5 Amgen Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Novel Drug Reconstitution System Major Product Offerings
7.15.4 Roche Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 GlaxoSmithKline
7.16.1 GlaxoSmithKline Company Summary
7.16.2 GlaxoSmithKline Business Overview
7.16.3 GlaxoSmithKline Novel Drug Reconstitution System Major Product Offerings
7.16.4 GlaxoSmithKline Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.16.5 GlaxoSmithKline Key News & Latest Developments
7.17 Vertex Pharmaceuticals
7.17.1 Vertex Pharmaceuticals Company Summary
7.17.2 Vertex Pharmaceuticals Business Overview
7.17.3 Vertex Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.17.4 Vertex Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.17.5 Vertex Pharmaceuticals Key News & Latest Developments
7.18 Synergy Pharmaceuticals
7.18.1 Synergy Pharmaceuticals Company Summary
7.18.2 Synergy Pharmaceuticals Business Overview
7.18.3 Synergy Pharmaceuticals Novel Drug Reconstitution System Major Product Offerings
7.18.4 Synergy Pharmaceuticals Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.18.5 Synergy Pharmaceuticals Key News & Latest Developments
7.19 Otsuka Pharmaceutical
7.19.1 Otsuka Pharmaceutical Company Summary
7.19.2 Otsuka Pharmaceutical Business Overview
7.19.3 Otsuka Pharmaceutical Novel Drug Reconstitution System Major Product Offerings
7.19.4 Otsuka Pharmaceutical Novel Drug Reconstitution System Sales and Revenue in Global (2018-2023)
7.19.5 Otsuka Pharmaceutical Key News & Latest Developments
8 Global Novel Drug Reconstitution System Production Capacity, Analysis
8.1 Global Novel Drug Reconstitution System Production Capacity, 2018-2029
8.2 Novel Drug Reconstitution System Production Capacity of Key Manufacturers in Global Market
8.3 Global Novel Drug Reconstitution System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Novel Drug Reconstitution System Supply Chain Analysis
10.1 Novel Drug Reconstitution System Industry Value Chain
10.2 Novel Drug Reconstitution System Upstream Market
10.3 Novel Drug Reconstitution System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Novel Drug Reconstitution System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Novel Drug Reconstitution System in Global Market
Table 2. Top Novel Drug Reconstitution System Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Novel Drug Reconstitution System Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Novel Drug Reconstitution System Revenue Share by Companies, 2018-2023
Table 5. Global Novel Drug Reconstitution System Sales by Companies, (K Units), 2018-2023
Table 6. Global Novel Drug Reconstitution System Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Novel Drug Reconstitution System Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Novel Drug Reconstitution System Product Type
Table 9. List of Global Tier 1 Novel Drug Reconstitution System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Drug Reconstitution System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Novel Drug Reconstitution System Sales (K Units), 2018-2023
Table 15. By Type - Global Novel Drug Reconstitution System Sales (K Units), 2024-2029
Table 16. By Application – Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Novel Drug Reconstitution System Sales (K Units), 2018-2023
Table 20. By Application - Global Novel Drug Reconstitution System Sales (K Units), 2024-2029
Table 21. By Region – Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Novel Drug Reconstitution System Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Novel Drug Reconstitution System Sales (K Units), 2018-2023
Table 25. By Region - Global Novel Drug Reconstitution System Sales (K Units), 2024-2029
Table 26. By Country - North America Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Novel Drug Reconstitution System Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Novel Drug Reconstitution System Sales, (K Units), 2018-2023
Table 29. By Country - North America Novel Drug Reconstitution System Sales, (K Units), 2024-2029
Table 30. By Country - Europe Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Novel Drug Reconstitution System Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Novel Drug Reconstitution System Sales, (K Units), 2018-2023
Table 33. By Country - Europe Novel Drug Reconstitution System Sales, (K Units), 2024-2029
Table 34. By Region - Asia Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Novel Drug Reconstitution System Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Novel Drug Reconstitution System Sales, (K Units), 2018-2023
Table 37. By Region - Asia Novel Drug Reconstitution System Sales, (K Units), 2024-2029
Table 38. By Country - South America Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Novel Drug Reconstitution System Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Novel Drug Reconstitution System Sales, (K Units), 2018-2023
Table 41. By Country - South America Novel Drug Reconstitution System Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Novel Drug Reconstitution System Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Novel Drug Reconstitution System Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Novel Drug Reconstitution System Sales, (K Units), 2024-2029
Table 46. 3M Innovative Properties Company Summary
Table 47. 3M Innovative Properties Novel Drug Reconstitution System Product Offerings
Table 48. 3M Innovative Properties Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. 3M Innovative Properties Key News & Latest Developments
Table 50. Baxter Company Summary
Table 51. Baxter Novel Drug Reconstitution System Product Offerings
Table 52. Baxter Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Baxter Key News & Latest Developments
Table 54. JW Group Company Summary
Table 55. JW Group Novel Drug Reconstitution System Product Offerings
Table 56. JW Group Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. JW Group Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Novel Drug Reconstitution System Product Offerings
Table 60. Pfizer Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Novel Drug Reconstitution System Product Offerings
Table 64. Takeda Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. Aerie Pharmaceuticals Company Summary
Table 67. Aerie Pharmaceuticals Novel Drug Reconstitution System Product Offerings
Table 68. Aerie Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Aerie Pharmaceuticals Key News & Latest Developments
Table 70. Ionis Pharmaceuticals Company Summary
Table 71. Ionis Pharmaceuticals Novel Drug Reconstitution System Product Offerings
Table 72. Ionis Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Ionis Pharmaceuticals Key News & Latest Developments
Table 74. Eisai Company Summary
Table 75. Eisai Novel Drug Reconstitution System Product Offerings
Table 76. Eisai Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Eisai Key News & Latest Developments
Table 78. Covis Pharma Company Summary
Table 79. Covis Pharma Novel Drug Reconstitution System Product Offerings
Table 80. Covis Pharma Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Covis Pharma Key News & Latest Developments
Table 82. Allergan Company Summary
Table 83. Allergan Novel Drug Reconstitution System Product Offerings
Table 84. Allergan Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Allergan Key News & Latest Developments
Table 86. Gilead Sciences Company Summary
Table 87. Gilead Sciences Novel Drug Reconstitution System Product Offerings
Table 88. Gilead Sciences Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Gilead Sciences Key News & Latest Developments
Table 90. Bayer Healthcare Company Summary
Table 91. Bayer Healthcare Novel Drug Reconstitution System Product Offerings
Table 92. Bayer Healthcare Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Bayer Healthcare Key News & Latest Developments
Table 94. Credence Medsystems Company Summary
Table 95. Credence Medsystems Novel Drug Reconstitution System Product Offerings
Table 96. Credence Medsystems Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Credence Medsystems Key News & Latest Developments
Table 98. Amgen Company Summary
Table 99. Amgen Novel Drug Reconstitution System Product Offerings
Table 100. Amgen Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Amgen Key News & Latest Developments
Table 102. Roche Company Summary
Table 103. Roche Novel Drug Reconstitution System Product Offerings
Table 104. Roche Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Roche Key News & Latest Developments
Table 106. GlaxoSmithKline Company Summary
Table 107. GlaxoSmithKline Novel Drug Reconstitution System Product Offerings
Table 108. GlaxoSmithKline Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. GlaxoSmithKline Key News & Latest Developments
Table 110. Vertex Pharmaceuticals Company Summary
Table 111. Vertex Pharmaceuticals Novel Drug Reconstitution System Product Offerings
Table 112. Vertex Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Vertex Pharmaceuticals Key News & Latest Developments
Table 114. Synergy Pharmaceuticals Company Summary
Table 115. Synergy Pharmaceuticals Novel Drug Reconstitution System Product Offerings
Table 116. Synergy Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Synergy Pharmaceuticals Key News & Latest Developments
Table 118. Otsuka Pharmaceutical Company Summary
Table 119. Otsuka Pharmaceutical Novel Drug Reconstitution System Product Offerings
Table 120. Otsuka Pharmaceutical Novel Drug Reconstitution System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Otsuka Pharmaceutical Key News & Latest Developments
Table 122. Novel Drug Reconstitution System Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Novel Drug Reconstitution System Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Novel Drug Reconstitution System Production by Region, 2018-2023 (K Units)
Table 125. Global Novel Drug Reconstitution System Production by Region, 2024-2029 (K Units)
Table 126. Novel Drug Reconstitution System Market Opportunities & Trends in Global Market
Table 127. Novel Drug Reconstitution System Market Drivers in Global Market
Table 128. Novel Drug Reconstitution System Market Restraints in Global Market
Table 129. Novel Drug Reconstitution System Raw Materials
Table 130. Novel Drug Reconstitution System Raw Materials Suppliers in Global Market
Table 131. Typical Novel Drug Reconstitution System Downstream
Table 132. Novel Drug Reconstitution System Downstream Clients in Global Market
Table 133. Novel Drug Reconstitution System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Novel Drug Reconstitution System Segment by Type in 2022
Figure 2. Novel Drug Reconstitution System Segment by Application in 2022
Figure 3. Global Novel Drug Reconstitution System Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Drug Reconstitution System Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Novel Drug Reconstitution System Revenue, 2018-2029 (US$, Mn)
Figure 7. Novel Drug Reconstitution System Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Novel Drug Reconstitution System Revenue in 2022
Figure 9. By Type - Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 11. By Type - Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 12. By Type - Global Novel Drug Reconstitution System Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 15. By Application - Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 16. By Application - Global Novel Drug Reconstitution System Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Novel Drug Reconstitution System Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Novel Drug Reconstitution System Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 20. By Region - Global Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 21. By Country - North America Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 22. By Country - North America Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 23. US Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 28. Germany Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 29. France Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 37. China Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 41. India Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 43. By Country - South America Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 44. Brazil Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Novel Drug Reconstitution System Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Novel Drug Reconstitution System Sales Market Share, 2018-2029
Figure 48. Turkey Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Novel Drug Reconstitution System Revenue, (US$, Mn), 2018-2029
Figure 52. Global Novel Drug Reconstitution System Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Novel Drug Reconstitution System by Region, 2022 VS 2029
Figure 54. Novel Drug Reconstitution System Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 新型薬物再構成システムの世界市場見通し2023年-2029年(Novel Drug Reconstitution System Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • I型高リポタンパク血症治療薬の世界市場見通し2023年-2029年
  • アセタゾラミド薬の世界市場見通し2023年-2029年
  • 高シュウ酸尿症一次治療薬の世界市場見通し2023年-2029年
  • 脳神経外科用薬剤の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆